35 results
424B3
PRTG
Portage Biotech Inc
7 Nov 23
Prospectus supplement
4:50pm
patent protection for our products;
the recruitment or departure of key personnel;
market conditions in the pharmaceutical and biotechnology sectors
F-1
PRTG
Portage Biotech Inc
31 Oct 23
Registration statement (foreign)
4:05pm
or other proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our products;
the recruitment
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
, including patents, litigation matters and our ability to obtain patent protection for our products;
the recruitment or departure of key personnel
424B5
r5ra6ecovz
19 Aug 22
Prospectus supplement for primary offering
10:52am
SUPPL
iarbk6h1vkn2tiz
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
c0xr0ox
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B5
icr9kb3l1r
8 Mar 21
Prospectus supplement for primary offering
5:03pm
F-3
jpabbk6zkkwf3h2
24 Feb 21
Shelf registration (foreign)
5:22pm
6-K
EX-99.1
np5f6uoryhh5203z vei
28 May 20
Report of Foreign Private Issuer
12:19pm
6-K
l8e jd7fnbt
16 Apr 20
Report of Foreign Private Issuer
11:27am
6-K
EX-99.2
4qrptna7bkk8ch
31 Dec 19
Consolidated Interim Financial Statements
10:03am
6-K
98yls7mq50hwikv15tq2
11 Jul 19
Report of Foreign Issuer
1:36pm
6-K
EX-99.1
7s9tsyf2 5ixpgl
19 Feb 19
Report of Foreign Private Issuer
10:37am